首页> 外文期刊>British Journal of Radiology >Post-operative adjuvant thoracic radiotherapy for patients with completely resected non-small cell lung cancer with nodal involvement: outcome and prognostic factors.
【24h】

Post-operative adjuvant thoracic radiotherapy for patients with completely resected non-small cell lung cancer with nodal involvement: outcome and prognostic factors.

机译:术后辅助胸部放疗患者全切除的非小细胞肺癌,节点参与:结果和预后因素。

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of this study was to analyse the outcome and prognostic factors of non-small cell lung cancer (NSCLC) patients with nodal disease treated by complete tumour resection followed by radiotherapy alone. Between October 1990 and October 1999, 49 NSCLC patients with N1 or N2 stage were treated with complete resection of tumour followed by post-operative radiotherapy in our department. The radiation was delivered with 10 MV X-rays given 5 days per week at 1.8-2 Gy per fraction. Total doses ranged from 40 Gy to 64.8 Gy, with a median dose of 55.8 Gy. All patients had at least 30 months of follow-up. The 5 year overall survival rate (OS), local control rate (LC) and distant metastasis-free rate (DMF) were 34%, 52% and 29%, respectively. In multivariate analysis, stage and margin were found to influence OS. The total number of involved lymph nodes and positive margins were significant factors for LC. Only N stage was found to correlate with DMF. In conclusion, patients with multiple involved lymph nodes, advanced stage or positive surgical margins had a poor outcome even with post-operative radiotherapy. Based on these prognostic factors, new therapeutic regimens and modalities for NSCLC need to be further investigated.
机译:本研究的目的是分析非小细胞肺癌(NSCLC)患者通过完全肿瘤切除治疗的核心疾病患者的结果和预后因素,然后单独进行放射治疗。 1990年10月至1999年10月期间,49例N1或N2阶段的N1或N2患者被完全切除肿瘤治疗,然后在我们的部门进行后术后放疗。辐射用10mV X射线递送,每周5天给出,每分馏分为1.8-2Gy。总剂量范围为40 GY至64.8 GY,中间剂量为55.8 GY。所有患者均至少有30个月的随访。 5年总存活率(OS),局部控制率(LC)和远处转移率(DMF)分别为34%,52%和29%。在多变量分析中,发现阶段和边际会影响OS。涉及淋巴结的总数和阳性边缘是LC的重要因素。发现只有N阶段与DMF相关。总之,患有多个涉及的淋巴结,晚期或阳性手术边距的患者即使在手术后放疗也具有较差的结果。基于这些预后因素,需要进一步研究新的治疗方案和NSCLC的模式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号